Cosette debuts generic Aczone

Cosette, in partnership with SeegPharm SA, is introducing Dapsone 5% gel, which is a generic of Almirall’s Aczone.

The product is used to treat acne.

Apurva Saraf, president and CEO of Cosette, said, “This launch further validates Cosette’s ability to successfully partner globally and launch affordable, high-quality drugs. We are staying true to our motto ‘Innovating Every Day’ and are committed to being a trusted partner of choice, while continuing the important work of serving U.S. patients and prescribers through R&D and Global Business Development partnerships.”

[Read more: Winning the beauty pageant: Drug stores want more timely, trendy beauty offerings]

Dapsone 5% gel had a market value of approximately $20 million for the 12 months ended December 2022, according to IQVIA.